Assessing lung tumor motion with dynamic MRI
Official title: RealMove (Lung): Assessing Tumour Motion With Dynamic MRI
Run by Region Stockholm · NCT06322329 · Data updated 2026-11-12
This study is testing if using dynamic MRI can better track lung tumor movement during breathing compared to standard 4D CT scans for patients getting targeted radiation therapy.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 150 (estimated) |
| Sponsor | Region Stockholm Government |
| Locations | 1 site (Stockholm) |
| Status | Recruiting |
| Started | March 15, 2024 |
| Main results expected | March 17, 2026 |
| Study ends | March 17, 2036 |
| Registry record updated | September 2, 2025 |
| Trial ID | NCT06322329 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18 and older who are scheduled for SBRT treatment of lung tumors located below the carina.
✕Probably not a fit
Patients who are pregnant, breastfeeding, or have contraindications for MRI will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to improve the treatment of lung tumors by using dynamic MRI to assess tumor motion during the respiratory cycle. It compares the effectiveness of dynamic MRI against the standard 4D CT imaging in tailoring the safety margins for stereotactic body radiotherapy (SBRT). Patients receiving SBRT for lung tumors located below the carina will participate, undergoing both imaging techniques to evaluate tumor motion and its impact on treatment outcomes. The study also includes monitoring patient anxiety levels during imaging sessions to understand its influence on breathing patterns.
Why it matters
Potential benefit: If successful, this approach could lead to more precise radiotherapy treatments, minimizing damage to healthy tissues while effectively targeting tumor cells.
How similar studies have gone: Other studies have shown promise in using advanced imaging techniques for tumor motion assessment, suggesting potential success for this approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Accepted for SBRT treatment of one or more caudally situated lung targets (NSCLC or metastases), i.e. below the carina. * Age ≥ 18 years * Adequate clinical condition to maintain immobilised position for at least 30 minutes * Adequate Swedish skills and cognitive function to understand study information and to fill in the questionnaire Exclusion Criteria: * Pregnancy or breastfeeding, or planned pregnancy or breastfeeding, during treatment * Contraindication for MRI examination * Otherwise incapable of participating in study
Where it's running
-
Karolinska University Hospital
Stockholm, Sweden Recruiting
Study contacts
- Principal investigator: Eva Onjukka, PhD — Karolinska University Hospital/Karolinska Institutet
- Study coordinator: Mattias Hedman, MD PhD
- Email: mattias.hedman@regionstockholm.se
- Phone: +46812370000
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Evaluating the impact of MR-guided radiation therapy on cancer treatment outcomes
This study is testing how using a special type of radiation therapy with real-time imaging can improve treatment results and quality of life for adults with cancer.
-
Group CBT vs. Activity Group for Adults with ADHD
This trial tests whether group cognitive behavioral therapy helps adults with ADHD more than a structured activity group.
-
AI support in emergency medicine helps doctors make differential diagnoses
This study tests whether a generative AI tool can help emergency doctors arrive at more accurate differential diagnoses for adult patients at Karolinska University Hospital.
-
Predicting prostate cancer response to neoadjuvant darolutamide with a gene biomarker
This study tests whether a gene-based PCAI ImmunoScore can predict which high-risk localized or locally advanced prostate cancer patients will have minimal residual disease after 90–120 days of darolutamide before surgery.
-
Pulse palpation vs arterial blood pressure in circulatory shock
This study tests how well feeling for a pulse at typical sites matches the actual arterial blood pressure in adults with circulatory shock or risk of failure.
-
Brief Cognitive Behavioral Therapy for Inpatient Psychiatry
This project tests whether a brief CBT program added to usual inpatient care helps adults with depression or anxiety during their hospital stay.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.